MedPath
TGA Approval

APO-MEBEVERINE mebeverine hydrochloride 135 mg tablet blister pack (288817)

288817

APO-MEBEVERINE mebeverine hydrochloride 135 mg tablet blister pack

Arrotex Pharmaceuticals Pty Ltd

April 4, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/73ef5bbbbc0e1666cb6664e1c86a5588.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/76ed4391443c8e5db5d3dd67a118bbde.pdf

Active Ingredients

mebeverine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-MEBEVERINE mebeverine hydrochloride 135 mg tablet blister pack (288817) - TGA 批准文号 | MedPath